Reactive plasmacytosis



OVERVIEW

OVERVIEW

Reactive plasmacytosis refers to a group of clinical syndromes characterized by an increase in the number of mature plasma cells in the bone marrow, caused by a variety of reasons or primary diseases. Under normal conditions, plasma cells do not appear in the peripheral blood, but they can appear in pathological conditions. Intramedullary plasmacytosis can occur in the presence of different antigenic stimuli, metabolic reactions, autoimmune disorders, and neoplasms.

Whether medical insurance

Yes

Department

Hematology

Synonyms

Plasmacytosis, Reactive plasmacytosis

Clinical symptoms

Associated with the primary disease, such as fever, malaise, lethargy and pallor.

Hazards

Related to the hazards of the primary disease, which may cause hemolytic anemia, acquired vascular hemophilia, or hypoglycemia.

Complications

Hemolytic anemia, acquired vascular hemophilia, hypoglycemia, etc.

Examination

Physical examination, blood routine, serum immunoglobulin determination, bone marrow cytology, immunofixation electrophoresis, etc.

Diagnosis

Diagnosis can be made on the basis of history and clinical manifestations, combined with >3% increase in mature plasma cells in the bone marrow, and exclusion of other diseases.

Treatment principle

Actively treat the primary disease and use immunosuppressant therapy if necessary.

Curability

Aggressive treatment of the primary disease may relieve symptoms.

Dietary recommendations

Dietary programs are formulated according to the primary disease.

Etiology

Etiology

Can be caused by infection, tumor, allergic disease, hematopoietic system disease, etc.

Symptoms and Diagnosis

Typical symptoms

Related to the original disease, there may be fever, fatigue, emaciation, pallor, jaundice, bruises, petechiae and other manifestations.

Diagnostic basis

1. Existence of etiology or primary disease causing reactive plasma cell increase, such as viral infection, allergic disease, connective tissue disease, tuberculosis, chronic liver disease, malignant tumor, aplastic anemia, myelodysplastic syndrome, etc. 2. Clinical manifestations related to the primary disease. 3. Immunoglobulin is normal or increased, and immune-fixed electrophoresis shows polyclonality; plasma cell increase in bone marrow is >3% for mature plasma cells.

Treatment

Treatment guidelines

Treat the primary disease and remove the cause; use immunosuppressant therapy if necessary.

Drug therapy

When hemolytic anemia, acquired vascular hemophilia, and hypoglycemia are caused, adrenocorticotropic hormone or other immunosuppressive therapy may be tried.

Prognosis

Whether reactive plasmacytosis improves or not depends on the treatment effect of the primary disease, and plasmacytosis may disappear only after the primary disease is cured.

Nursing care

Daily care

1. The environment should be maintained at a suitable temperature and humidity, and ventilated frequently. Patients should wear breathable, cotton clothes, and should be kept warm if they have chills.2. Rest and activitiesPatients should have sufficient rest, live a regular life, avoid exertion, and take activities to the extent that they do not feel fatigue, and maintain sufficient sleep to prevent aggravation of the condition.3. Prevention of infectionKeep the environment clean and hygienic and the patients’ organisms clean, to prevent the spread of bacteria in the body, and to do a good job of oral care, perineal-anal care and prevention of all kinds of infections.4. Psychology Nursing family members take the initiative to communicate with patients, promote the interactive relationship between patients and their families, and take the initiative to participate in the care of patients in order to reduce the patient’s inner sense of depression.

Diet regulation

According to the primary disease to develop a corresponding diet program.